Suture Needles Market

A surge in the number of surgical procedures for cardiovascular diseases is driving the market growth

The rise of chronic diseases and an increase in the number of surgeries for cardiovascular conditions are driving the market's expansion. Furthermore, the development of cutting-edge technical solutions will help the market for suture needles. For instance, Healthium Medtech unveiled Truglyde SN2355, a set of suture needles created exclusively for COMOC MG, a novel surgical strategy for treating postpartum haemorrhage (PPH), one of the main causes of maternal death, in May 2020.

The WHO estimates that 2,94,046 deaths worldwide and more than 42,48,389 recorded cases of COVID-19 occurred in May 2020.  healthcare delivery has been significantly disrupted by the epidemic, especially efforts to treat chronic ailments like heart disease. Cardiology diagnostic procedures were down 64% overall from the prior year across all geographical areas. On the other hand, 22% of centres reported a lack of high-filtration masks and personal protective equipment (PPE) for medical staff, which restricted their ability to provide care. This supply crunch has had an adverse impact on the suture needle market.

The demand for surgical care is expected to increase due to the increased frequency of cardiovascular diseases worldwide. According to the WHO, 17.9 million deaths ly from cardiovascular diseases—or 32% of all deaths—occurred in 2019. Furthermore, a sizable fraction of these fatalities may be caused by heart attacks and strokes.

The market is expected to increase as a result of numerous initiatives, including product launches, mergers, and acquisitions by significant industry participants. For instance, Ethicon, a division of Johnson & Johnson Medical Devices Companies, introduced The ProxiSure (TM) Suturing Device in August 2017 as a cutting-edge laparoscopic suturing device incorporating Ethicon endomechanical, suture, and curved needle technology. With a very intuitive tissue healing experience, ProxiSure (TM) was created to deliver precision suturing in constrained areas. It is especially well-suited for bariatric, general, colorectal, and gynaecological surgeries.

The device's curved needle also enhances a surgeon's ability to suture a variety of tissue layers, including flat surfaces. Consequently, it is anticipated that the market for suture needles will expand as a result of such new developments. Thus, driving the Suture Needle market revenue.

The Global Suture Needle Market Industry is poised for substantial growth, with projections indicating a market value of 4.51 USD Billion in 2024 and an anticipated increase to 30.0 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 18.81% from 2025 to 2035, driven by various factors such as technological advancements, rising surgical procedures, and an increasing geriatric population. These metrics underscore the dynamic nature of the market and its potential to adapt to evolving healthcare demands.

The Global Suture Needle Market Industry experiences growth due to the increasing number of surgical procedures performed worldwide. As healthcare systems evolve and expand, the demand for surgical interventions rises, leading to a higher requirement for suture needles. For instance, the World Health Organization indicates that surgical procedures are projected to increase significantly, with estimates suggesting a rise from 234 million surgeries annually to over 400 million by 2030. This surge directly correlates with the anticipated market value of 4.51 USD Billion in 2024, as healthcare providers seek efficient and reliable suture solutions.

Technological innovations play a crucial role in shaping the Global Suture Needle Market Industry. The development of advanced materials and designs enhances the performance and efficacy of suture needles. For example, the introduction of absorbable sutures and needles made from biocompatible materials has improved patient outcomes and reduced recovery times. These advancements not only cater to the growing demand for minimally invasive procedures but also align with the projected market growth, which is expected to reach 30.0 USD Billion by 2035, reflecting a compound annual growth rate of 18.81% from 2025 to 2035.

The aging population worldwide significantly influences the Global Suture Needle Market Industry. As individuals age, they often require more surgical interventions due to age-related health issues. The United Nations projects that the global population aged 65 and older will reach 1.5 billion by 2050, creating a substantial demand for surgical procedures and, consequently, suture needles. This demographic shift is likely to propel the market forward, as healthcare systems adapt to meet the needs of an older population requiring more surgical care.

The Global Suture Needle Market Industry benefits from the increasing popularity of aesthetic and cosmetic procedures. As societal norms shift towards enhanced physical appearance, the demand for cosmetic surgeries rises. According to the American Society of Plastic Surgeons, millions of cosmetic procedures are performed annually, contributing to the growing need for specialized suture needles. This trend not only expands the market but also encourages innovation in needle design to cater to specific aesthetic applications, further driving the market's growth trajectory.

The rising prevalence of chronic diseases globally significantly impacts the Global Suture Needle Market Industry. Conditions such as diabetes, cardiovascular diseases, and cancer necessitate surgical interventions, thereby increasing the demand for suture needles. According to the Centers for Disease Control and Prevention, chronic diseases account for seven out of ten deaths in the United States, highlighting the urgent need for surgical solutions. This trend is likely to drive the market value upwards, as healthcare providers increasingly rely on effective suturing techniques to manage complex surgical cases.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Suture Needle Market dominated this market in 2022 (45.80%). This is achievable because cardiovascular illnesses, which currently account for more than one-third of all fatalities in the United States, are quite common and have a quick uptake of minimally invasive therapy. The American Heart Association predicts that by 2030, there will be twice as many old people as there are now, and that cardiovascular diseases will continue to be the leading cause of mortality and morbidity among them.

Further, the U.S. Suture Needle market held the largest market share, and the Canada Suture Needle market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  SUTURE NEEDLE MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Suture Needle market accounted for the healthy market share in 2022. This is because to things like a high number of surgeries, a rise in consumer disposable income, and the launch of technologically advanced items as a result of market participants investing in the area. Further, the German Suture Needle market held the largest market share, and the U.K Suture Needle market was the fastest growing market in the European region

The Asia Pacific Suture Needle market is expected to register significant growth from 2023 to 2032. The growth in surgical operations and medical tourism is a key factor driving the market in emerging nations. As a result, market expansion is probably going to pick up speed soon. Moreover, China’s Suture Needle market held the largest market share, and the Indian Suture Needle market was the fastest growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Suture Needle market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Suture Needle Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Suture Needle Industry to benefit clients and increase the market sector. In recent years, the Suture Needle Industry has offered some of the most significant advantages to medicine. Major players in the Suture Needle market, including Hu-Friedy Mfg. Co., Roboz Surgical Instrument, Hill-Rom, Medline Industries Inc., B. Braun Melsungen AG, Medtronic Plc, and Johnson & Johnson Services Inc., are attempting to increase market demand by investing in research and development operations.

A medical technology firm called Medtronic Plc (Medtronic), originally known as Medtronic Inc., creates, develops, produces, and sells a variety of medical products. It provides products for the treatment of conditions such heart valve issues, heart failure, aortic, peripheral vascular, venou,s renal, and neurological problems, as well as spine and musculoskeletal issues, ear, nose, and throat conditions. Additionally, it offers biologic solutions for the dental and orthopaedic markets. In Asia Pacific, Europe, the Americas, the Middle East, and Africa, it provides its products to hospitals, third-party healthcare providers, clinics, institutions, including governmental health care programmes, distributors, and group purchasing organisations.

The headquarters of Medtronic are in Dublin, Ireland. A partnership between Medtronic and Vizient for an AI-powered video management system was announced in March 2022. This will make procedure videos accessible to surgical teams.

The development, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted technologies, knee and hip implants to replace sick, worn, or damaged joints, trauma-related items to stabilise fractures, and deformity repair operations. Additionally, it provides items for treating wounds as well as tools and materials for removing and repairing soft tissue.

Surgeons, nurses, nurse specialists, doctors, general practitioners, buying staff at hospitals, and health insurers are among the groups to which Smith & Nephew makes its goods available. The company sells its goods across Africa, the Middle East, Asia-Pacific, Europe, and North America. The UK's Hertfordshire county of Watford is home to Smith & Nephew's headquarters. Smith and Nephew announced in November 2020 that their recently created Novostitch Meniscal repair technology has a success rate of 82.6% when treating Horizontal Cleavage rips.